1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Clinical characteristics of patients with high-grade gliomas
Patient Age/Gender Diagnosis/Grade Tumor Location Interscan Interval (months) Interscan Treatment
1 58/F GBM WHO IV Rt temporal 3 GTR
2^{^a} 73/F AA WHO III Lt temporal 8 –
3 44/M AGN WHO III/IV Lt frontoparietal 3 BVZ
4 62/F GBM WHO IV Rt temporal 5 BVZ
5 50/M OA WHO III Lt temporal 3 STR + BVZ
6 57/F GBM WHO IV Rt frontal 5 BVZ
7 35/M AA WHO III Lt frontoparietal 3 Chemotherapy/XRT
8 65/M GBM WHO IV Lt frontotemporal 2 STR + chemotherapy/XRT
9 49/M OA WHO III Lt frontotemporal 6 Chemotherapy/XRT
10^{^b} 67/M GBM WHO IV Lt parietal 1 GTR + chemotherapy/XRT
F indicates female; M, male; Lt, left; Rt, right; GBM, glioblastoma; AA, anaplastic astrocytoma; OA, oligoastrocytoma; AGN, anaplastic glioneural neoplasm; GTR, gross total resection; STR, subtotal resection; BVZ, bevacizumab; XRT, radiotherapy; WHO, World Health Organization.
↵a Chemotherapy/XRT was received 1 month prior to the initial scan.
↵b Newly diagnosed tumor at the time of the first scan. All other patients had recurrent tumor and surgical or medical management prior to the initial scan.